Healthcare News - An Overview
Novo CEO pressed by Senate to cut prices of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the company would take into account new talks with insurers with regards to the list prices of Wegovy and copyright whenever they pledge to maintain the medicines on their formularies.Elevance lowers steering on ‘unprecedent